Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis
Phytomedicine · 2026-09 · 159 · 158568
DOI: 10.1016/j.phymed.2026.158568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Wenjie Xu und 17 weiteren Autor:innen. Beteiligte Einrichtung: West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, Natural and Biomimetic Medicine R…. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Diosgenin, Drugs, Chinese Herbal, Pulmonary Fibrosis. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pulmonary fibrosis (PF) is a progressive, fatal interstitial lung disease with limited curative therapeutic options. Yin-Huang-Qing-Fei (YHQF) capsule is an approved clinical Chinese patent medicine with emerging preclinical evidence of potential anti-fibrotic bioactivity, yet its core anti-PF constituents, direct functional targets, and the druggability of its key active monomer remain largely uncharacterized. PURPOSE: This study aimed to decipher the anti-PF pharmacodynamic basis of YHQF, validate its core active constituent and functional target, and optimize the druggability of the candidate monomer. STUDY DESIGN: A randomized, controlled preclinical in vivo study was conducted, coupled with in vitro pharmacological validation, transcriptomic profiling, machine learning-based constituent screening, and genetic causal inference for target prioritization. METHODS: The anti-PF efficacy of YHQF was verified in bleomycin (BLM)-induced mouse PF models. Core bioactive constituents were screened via LC-MS/MS and machine learning. Mendelian randomization (MR) was used for target prioritization, followed by molecular docking, molecular dynamics simulation, surface plasmon resonance (SPR) and siRNA assays for multi-dimensional target validation. Transcriptomic profiling was conducted to elucidate the STAT3-associated downstream regulatory pathways. A diosgenin-metformin nanoconjugate (DM) was rationally designed for druggability optimization. RESULTS: YHQF significantly alleviated BLM-induced PF in mice. Diosgenin was identified as YHQF's core anti-PF constituent, with STAT3 validated as its direct functional target. Diosgenin exerted STAT3-dependent anti-fibrotic effects, and DM nanomicelles exhibited notably enhanced in vivo anti-PF efficacy. CONCLUSION: This study defined the diosgenin-STAT3 axis as the core mechanism mediating YHQF's anti-PF effect, develops an optimized nanomedicine with improved translational potential, and provides a practical, replicable strategy for traditional Chinese medicine modernization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- West China Center of Excellence for Pancreatitis, Institute of Integrated Traditional Chinese and Western Medicine, Natural and Biomimetic Medicine Research Center, Tissue-Orientated Property of Chinese Medicine Key Lab…
Zitieren
APA
Xu, W., Xin, G., Dong, Y., Zhou, Q., Wang, T., Wei, Z., Wen, A., Zhang, K., Li, F., Wang, Y., Feng, L., Xu, X., Yu, X., Wan, C., Li, Y., Deng, L., Xu, J., & Huang, W. (2026). Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. Phytomedicine, 159, 158568. https://doi.org/10.1016/j.phymed.2026.158568
Vancouver
Xu W, Xin G, Dong Y, Zhou Q, Wang T, Wei Z, et al. Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. Phytomedicine. 2026;159:158568. doi:10.1016/j.phymed.2026.158568
BibTeX
@article{Xu2026,
author = {Xu, Wenjie and Xin, Guang and Dong, Yuman and Zhou, Qilong and Wang, Tao and Wei, Zeliang and Wen, Ao and Zhang, Kun and Li, Fan and Wang, Yilan and Feng, Lijuan and Xu, Xinrui and Yu, Xiuxian and Wan, Chengyu and Li, Yancen and Deng, Lijing and Xu, Jianxin and Huang, Wen},
title = {Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis},
journal = {Phytomedicine},
year = {2026},
volume = {159},
pages = {158568},
doi = {10.1016/j.phymed.2026.158568}
}
EUVIMED